Model predicting survival / exitus after traumatic brain injury: Biomarker S100B 24H

Clinical Laboratory

Volumn 57, Issue 7-8, 2011, Pages 587-597

  Gonzalez Mao M C ^a   Reparaz Andrade A ^a   Del Campo Perez V ^a   Alvarez Garcia E ^a   Vara Perez, C ^a   Andrade Olivie M A ^a  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

Biomarkers; GCS; GOS; Model predicting; Negative prediction value (NPV); Positive prediction value (PPV); S100B; Traumatic Brain Injury (TBI)

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100B;

ADULT; AGED; AMNESIA; ARTICLE; BLOOD SAMPLING; BRAIN DAMAGE; BRAIN TUMOR; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG DEPENDENCE; FEMALE; GLASGOW COMA SCALE; HISTOPATHOLOGY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; MALE; MULTIPLE TRAUMA; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROLOGICAL INTENSIVE CARE UNIT; NEUROSURGERY; PREDICTIVE VALUE; PROGNOSIS; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; SURVIVAL RATE; TRAUMATIC BRAIN INJURY; UNCONSCIOUSNESS; URINALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMNESIA; BIOLOGICAL MARKERS; BRAIN INJURIES; COMA; DISEASE PROGRESSION; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, THEORETICAL; MULTIPLE TRAUMA; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; S100 PROTEINS; SENSITIVITY AND SPECIFICITY; SURVIVAL; YOUNG ADULT;

NUCLEOPOLYHEDROVIRUS;

EID: 80051762429     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Hergenroeder GW, Redell JB, Moore AN, Dash PK. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther 2008;12:345-58. (Pubitemid 352790449)
2. Baker AJ. Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients. J Neurotrauma 2009;26:1227-40.
3. Boto GR, Gomez PA, De la Cruz J, Lobato RD. [Prognostic factors in severe head injury]. Neurocirugia (Astur) 2004;15:233-47.
4. Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. Calcium-dependent and -independent interactions of the S100 protein family. Biochem J 2006;396:201-14. (Pubitemid 43837235)
5. Townend W, Ingebrigtsen T. Head injury outcome prediction: a role for protein S-100B? Injury 2006;37:1098-108.
6. Netto CB, Conte S, Leite MC, et al. Serum S100B protein is increased in fasting rats. Arch Med Res 2006;37:683-6. (Pubitemid 43782910)
7. Gazzolo D, Florio P, Zullino E, et al. S100B protein increases in human blood and urine during stressful activity. Clin Chem Lab Med;48:1363-5.
8. Routsi C, Stamataki E, Nanas S, et al. Increased levels of serum SlOOB protein in critically ill patients without brain injury. Shock 2006;26:20-4. (Pubitemid 44297001)
9. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004;62:1303-10. (Pubitemid 38526041)
10. Hu DL, Liu XH, Yu XL, et al. [Clinical significance of serum S-100B protein in severe cerebral injury]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004;16:221-2.
11. Rainey T, Lesko M, Sacho R, Lecky F, Childs C. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point. Resuscitation 2009;80:341-5.
12. Gabriel EJ, Ghajar J, Jagoda A, Pons PT, Scalea T, Walters BC. Guidelines for prehospital management of traumatic brain injury. J Neurotrauma 2002;19:111-74.
13. Marshall LF, Marshall SB, Klauber MR, et al. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma 1992;9 Suppl 1:S287-92.
14. Griffin WS, Stanley LC, Ling C, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 1989;86:7611-5. (Pubitemid 19254506)
15. Martenson ED, Hansson LO, Nilsson B, et al. Serum S-100B protein as a prognostic marker in malignant cutaneous melanoma. J Clin Oncol 2001;19:824-31. (Pubitemid 32119098)
16. Enochsson L, Carlsson-Sanz S, van der Linden J. The influence of alcohol and time on the S-100B levels of patients with minor head injury. Eur J Neurol 2005;12:445-8. (Pubitemid 40768663)
17. Braakman R. Early prediction of outcome in severe head injury. Acta Neurochir (Wien) 1992;116:161-3.
18. Ellenberg JH, Levin HS, Saydjari C. Posttraumatic Amnesia as a predictor of outcome after severe closed head injury. Prospective assessment. Arch Neurol 1996;53:782-91.
19. Cantu RC. Posttraumatic Retrograde and Anterograde Amnesia: Pathophysiology and Implications in Grading and Safe Return to Play. J Athl Train 2001;36:244-8.
20. Boto GR, Gomez PA, De la Cruz J, Lobato RD. [Prognostic models in severe head injury]. Neurocirugia (Astur) 2006;17:215-25.
21. Goncalves CA, Leite MC, Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008;41:755-63.
22. Leite MC, Galland F, Brolese G, et al. A simple, sensitive and widely applicable ELISA for S100B: Methodological features of the measurement of this glial protein. J Neurosci Methods 2008;169:93-9.
23. Nylen K, Ost M, Csajbok LZ, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien) 2008;150:221-7;discussion 7.
24. Blyth BJ, Farhavar A, Gee C, et al. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury. J Neurotrauma 2009;26:1497-507.
25. Margis R, Zanatto VC, Tramontina F, et al. Changes in S100B cerebrospinal fluid levels of rats subjected to predator stress. Brain Res 2004;1028:213-8. (Pubitemid 39446632)
26. Pelinka LE, Toegel E, Mauritz W, Redl H. Serum S100B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003;19:195-200.
27. Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V. S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res 2004;26:440-5.
28. Jackson RG, Samra GS, Radcliffe J, Clark GH, Price CP. The early fall in levels of S-100 beta in traumatic brain injury. Clin Chem Lab Med 2000;38:1165-7. (Pubitemid 32007775)
29. Snyder-Ramos SA, Bottiger BW. Molecular markers of brain damage-clinical and ethical implications with particular focus on cardiac arrest. Restor Neurol Neurosci 2003;21:123-39. (Pubitemid 37330253)
30. Mao MCG. S100B Protein as a Serum Marker of Survival After Traumatic Brain Injury (TBI). Clinical Chemistry 2009;55:A200-A.
31. Pang BC, Kuralmani V, Joshi R, et al. Hybrid outcome prediction model for severe traumatic brain injury. J Neurotrauma 2007;24:136-46. (Pubitemid 46214419)
32. Menon DK, Zahed C. Prediction of outcome in severe traumatic brain injury. Curr Opin Crit Care 2009;15:437-41.
33. Steyerberg EW, Mushkudiani N, Perel P, et al. Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med 2008;5:e165; discussion e.
34. Hayes RL, Robinson G, Muller U, Wang KK. Translation of neurological biomarkers to clinically relevant platforms. Methods Mol Biol 2009;566:303-13.
35. Saenger AK, Christenson RH. Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment. Clin Chem;56:21-33.